NEW YORK, Sept. 28, 2026 /PRNewswire/ -- TO: ALL RECORD HOLDERS AND ALL BENEFICIAL HOLDERS OF REVANCE THERAPEUTICS, INC. ("REVANCE" OR THE "COMPANY") COMMON STOCK WHO HELD SUCH STOCK AS OF THE FEBRUARY 6, 2025 CLOSING OF THE MERGER BETWEEN REVANCE AND CROWN LABORATORIES, INC. ("CROWN")...
Monteverde & Associates PC and Kahn Swick & Foti, LLC Announce Proposed Class Action Settlement on Behalf of Holders of Revance Therapeutics, Inc. Common Stock
